Research Article
Bone Mesenchymal Stem Cell-Derived Small Extracellular Vesicles Ameliorated Lipopolysaccharide-Induced Lung Injury Via the miR-21-5p/PCSK6 Pathway
Figure 6
BMSC-sEVs ameliorated LPS-induced BEAS-2B cells injury by delivering miR-21-5p. (a–c) RT-qPCR and western blotting were used to examine the expression of PCSK6 in monocultured BEAS-2B cells (control), and BEAS-2B cells cocultured with GW4869- or miR-21-5p inhibitor-treated BMSCs. (d) The proliferation of monocultured BEAS-2B cells and BEAS-2B cells cocultured with GW4869- or miR-21-5p inhibitor treated-BMSCs. (e, f). The TEER value and FITC-dextran of monocultured BEAS-2B cells and BEAS-2B cells cocultured with GW4869- or miR-21-5p inhibitor treated-BMSCs. vs. control. ## vs. LPS + GW4869. (g–i) NC-sEVs decreased LPS-induced PCSK6 mRNA and protein expression, whereas the inhibitor-sEV promoted no significant change in the LPS treatment group. vs. control. !!! vs. LPS. ##, and ## vs. LPS + NC-sEVs.
(a) |
(b) |
(c) |
(d) |
(e) |
(f) |
(g) |
(h) |
(i) |